A Review of Living with Lymphoma: A Patient's Guide

I am sure most of you have seen my earlier post on the new book Living with Lymphoma: A Patient's Guide by Elizabeth Adler. Not that many patient oriented books on lymphoma come out - this one was highly anticipated. It took me awhile to review because I wanted to read all of it. The book is divided into three parts: Part one: Living with Lymphoma and Part 2: Treating Lymphoma have the information most patients will be referring to. They are well written, informative and benefitial to people at differing levels of comprehension. Details such as talk of various chemotherapy drugs is well done. Dr. Adler writes with both authority and as a person who has been there. Refreshing.



That isn't to say that Part Three: Understanding Lymphoma isn't just as good - it is - but in a different way. Adler delves into cell biology, the immune system, and what is happening to our bodies at the cellular and molecular level. It is the most complete explaination of what goes on I've found and is excellent but even for me it took some time to read. It's the type of info you can read at your own pace if you like.



The book is very current on treatments, lymphoma types, and strategies. I highly recommend it for patients, loved ones, and anyone who would like to understand what is lymphoma. Available now at some bookstores or through Amazon.Com for 32% off.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap